Innate Pharma S.A. IPHA
1.43 USD +0.03 (+2.14%)
Nov 6, 2026, 1:53 PM EST
1.40 Day range 1.48
1.17 52-week range 2.71
- YTD
- -18.29%
- 1 year
- -20.56%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 9.01M | 20.12M | 61.64M | 57.67M | 24.70M | |
| 9.01M | 20.12M | 61.64M | 57.67M | 24.70M | |
| -54.01M | -51.58M | -12.67M | -57.42M | -47.83M | |
| -49.18M | -49.47M | -7.57M | -58.10M | -52.81M | |
| -0.55 | -0.61 | -0.09 | -0.73 | -0.66 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 28.09M | 66.40M | 70.61M | 84.22M | 103.76M | |
| 62.72M | 111.06M | 175.19M | 199.29M | 267.50M | |
| 84.42M | 102.22M | 123.29M | 145.14M | 160.06M | |
| 22.57M | 31.00M | 39.89M | 42.25M | 44.25M | |
| -21.70M | 8.83M | 51.90M | 54.15M | 107.44M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -52.76M | -6.90M | -32.56M | -19.16M | -58.46M | |
| 7.29M | 9.20M | 20.63M | 1.88M | -917.00K | |
| 6.07M | -6.01M | -1.97M | -1.83M | 26.82M | |
| -140.00K | -391.00K | -201.00K | -535.00K | -922.00K | |
| -38.30M | -4.21M | -13.62M | -19.53M | -33.04M |